D. Inthorn

发表

Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome

M. Wichmann, D. Inthorn, H. Andress, 2000, Intensive Care Medicine.

Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma.

D. Inthorn, T. Cohnert, W. Ertel, 1990, The Journal of trauma.

EFFECT OF ANTITHROMBIN III SUPPLEMENTATION ON INFLAMMATORY RESPONSE IN PATIENTS WITH SEVERE SEPSIS

D. Inthorn, J. Hoffmann, W. Hartl, 1998, Shock.

Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway.

D. Inthorn, M. Menger, B. Vollmar, 2000, American journal of physiology. Cell physiology.

Adverse Effect of Heparin on Antithrombin Action during Endotoxemia: Microhemodynamic and Cellular Mechanisms

D. Inthorn, F. Schildberg, M. Menger, 2002, Thrombosis and Haemostasis.

Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia*

D. Inthorn, F. Schildberg, M. Menger, 2004, Critical care medicine.

Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances.

D. Inthorn, E. Faist, W. Hartl, 1995, Contributions to nephrology.

Hydroxyethyl Starch (130 kD), but Not Crystalloid Volume Support, Improves Microcirculation during Normotensive Endotoxemia

D. Inthorn, F. Schildberg, M. Menger, 2002, Anesthesiology.

Tumor necrosis factor measurement and use of different anticoagulants: Possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes

D. Inthorn, E. Faist, M. Jochum, 1997, Inflammation Research.

Chronic left heart catheterization for microvascular blood flow determination in the rabbit: a minimally invasive technique using specially designed port devices.

D. Inthorn, F. Schildberg, D. Nolte, 2002, The Journal of surgical research.

Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure

D. Inthorn, M. Storck, W. Hartl, 1991, The Lancet.

Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma

D. Inthorn, T. Cohnert, W. Ertel, 1988 .

Possible Use of the Monocyte/Macrophage Activation Marker Neopterin for Clinical Monitoring of Sepsis-Related Multiorgan Failure

D. Inthorn, J. Troppmair, C. Huber, 1989 .

Undetected severe complication after elective lumbar surgery - How could it happen?

D. Inthorn, I. Sinicina, H. Pankratz, 2019, Legal medicine.

[Comparison between cimetidine-pirenzepine and antacids for the prevention of stress hemorrhage in intensive care patients. A controlled clinical study on 125 patients].

D. Inthorn, D. Hölzel, H. Kolb, 1985, Deutsche medizinische Wochenschrift.

pathwayby modulation of the cyclooxygenase Antithrombin reduces leukocyte adhesion during chronic

D. Inthorn, M. Menger, B. Vollmar, 2016 .

Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium

D. Inthorn, F. Schildberg, M. Menger, 2002, Critical care medicine.

The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure.

D. Inthorn, M. Menger, B. Vollmar, 2000, Shock.

Hemofiltration in human sepsis

D. Inthorn, E. Faist, M. Jochum, 1994 .

ANTITHROMBIN III SUPPLEMENTATION IN SEVERE SEPSIS: BENEFICIAL EFFECTS ON ORGAN DYSFUNCTION

D. Inthorn, M. Jochum, J. Hoffmann, 1997, Shock.

Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis

D. Inthorn, E. Faist, M. Jochum, 1996, Intensive Care Medicine.

Elimination of Inflammatory Mediators by Hemofiltration

D. Inthorn, J. Hoffmann, 1996, International Journal of Artificial Organs.

Pathobiochemistry of sepsis: role of proteinases, proteinase inhibitors and oxidizing agents.

D. Inthorn, M. Jochum, H. Fritz, 1986, Behring Institute Mitteilungen.

Quantification of Antithrombin Isoform Proportions in Plasma Samples of Healthy Subjects, Sepsis Patients, and in Antithrombin Concentrates

D. Inthorn, M. Jochum, J. Römisch, 2002, Pathophysiology of Haemostasis and Thrombosis.

Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis*

D. Inthorn, M. Jochum, J. Hoffmann, 2004, Critical care medicine.

D‐erythro‐neopterin plasma levels in intensive care patients with and without septic complications

D. Inthorn, H. Redl, G. Schlag, 1987, Critical care medicine.

EXTRACORPOREAL PLASMA TREATMENT FOR THE REMOVAL OF ENDOTOXIN IN PATIENTS WITH SEPSIS: CLINICAL RESULTS OF A PILOT STUDY

D. Inthorn, D. Nagel, D. Seidel, 2005, Shock.

Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction – preliminary results

D. Inthorn, K. Jauch, W. Hartl, 2004, Liver international : official journal of the International Association for the Study of the Liver.

Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumors.

D. Inthorn, I. Assfalg-Machleidt, W. Machleidt, 1988, Biological chemistry Hoppe-Seyler.

Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds.

D. Inthorn, K. Werdan, E. Faist, 1999, Shock.

Septic shock and multiple organ failure: Treatment with haemofiltration?

D. Inthorn, M. Storck, W. Hartl, 1991, Intensive Care Medicine.

Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances.

D. Inthorn, E. Faist, M. Jochum, 1995, Kidney international.

Reactive hyperemia in patients with septic conditions.

D. Inthorn, G. Heberer, W. Hartl, 1988, Surgery.

Studies of granulocyte function (chemiluminescence response) in postoperative infection.

D. Inthorn, H. Redl, M. Jochum, 1987, Progress in clinical and biological research.

[Postoperative infusion therapy: electrolyte solution in comparison with hypocaloric glucose and carbohydrate exchange-amino acid solutions].

D. Inthorn, K. Jauch, W. Hartl, 1995, Zentralblatt fur Chirurgie.